Market Expansion HS1 Global is actively targeting North American markets with a focus on stabilizing medical pricing and improving logistics reliability, offering significant opportunities to collaborate with healthcare providers and government agencies engaged in COVID-19 testing and PPE procurement.

Product Portfolio The company's flagship product, the COVIBLOCK™ COVID-19 antibody test kit, is revenue positive via government funding, indicating strong demand for rapid testing solutions across clinics and hospitals looking to enhance their COVID-19 testing capabilities.

Growth Potential With a revenue range of 1 to 10 million dollars and a dedicated supply of PPE and testing kits, HS1 Global presents an opportunity for sales expansion in the medical supplies sector driven by ongoing pandemic-related healthcare needs.

Technology Use Leveraging digital tools like Google Analytics and cloud-based services positions HS1 Global to effectively reach healthcare customers, identify demand trends, and tailor marketing strategies to boost sales within the competitive medical equipment landscape.

Strategic Partnerships The company’s emphasis on government-funded testing solutions suggests a strategic opening to partner with public health organizations and procurement agencies seeking reliable, cost-effective COVID-19 testing and PPE supplies.